Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 103

1.

Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases.

Harrell CR, Jovicic N, Djonov V, Arsenijevic N, Volarevic V.

Cells. 2019 Dec 11;8(12). pii: E1605. doi: 10.3390/cells8121605. Review.

2.

Metabolic syndrome attenuates ulcerative colitis: Correlation with interleukin-10 and galectin-3 expression.

Jovanovic M, Simovic Markovic B, Gajovic N, Jurisevic M, Djukic A, Jovanovic I, Arsenijevic N, Lukic A, Zdravkovic N.

World J Gastroenterol. 2019 Nov 21;25(43):6465-6482. doi: 10.3748/wjg.v25.i43.6465.

3.

The role of Interleukin 1 receptor antagonist in mesenchymal stem cell-based tissue repair and regeneration.

Harrell CR, Markovic BS, Fellabaum C, Arsenijevic N, Djonov V, Volarevic V.

Biofactors. 2019 Nov 22. doi: 10.1002/biof.1587. [Epub ahead of print] Review.

PMID:
31755595
4.

Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.

Volarevic V, Markovic BS, Jankovic MG, Djokovic B, Jovicic N, Harrell CR, Fellabaum C, Djonov V, Arsenijevic N, Lukic ML.

Theranostics. 2019 Aug 14;9(20):5976-6001. doi: 10.7150/thno.33959. eCollection 2019.

5.

Galectin-3 Regulates Indoleamine-2,3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a Valuable Biomarker for Monitoring the Progression of Ulcerative Colitis.

Volarevic V, Zdravkovic N, Harrell CR, Arsenijevic N, Fellabaum C, Djonov V, Lukic ML, Simovic Markovic B.

Cells. 2019 Jul 12;8(7). pii: E709. doi: 10.3390/cells8070709.

6.

Gal-3 Deficiency Suppresses Novosphyngobium aromaticivorans Inflammasome Activation and IL-17 Driven Autoimmune Cholangitis in Mice.

Arsenijevic A, Milovanovic J, Stojanovic B, Djordjevic D, Stanojevic I, Jankovic N, Vojvodic D, Arsenijevic N, Lukic ML, Milovanovic M.

Front Immunol. 2019 Jun 7;10:1309. doi: 10.3389/fimmu.2019.01309. eCollection 2019.

7.

Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future Perspectives.

Harrell CR, Sadikot R, Pascual J, Fellabaum C, Jankovic MG, Jovicic N, Djonov V, Arsenijevic N, Volarevic V.

Stem Cells Int. 2019 May 2;2019:4236973. doi: 10.1155/2019/4236973. eCollection 2019. Review.

8.

IL-33/IL-33R in various types of carotid artery atherosclerotic lesions.

Stankovic M, Ljujic B, Babic S, Maravic-Stojkovic V, Mitrovic S, Arsenijevic N, Radak D, Pejnovic N, Lukic ML.

Cytokine. 2019 Aug;120:242-250. doi: 10.1016/j.cyto.2019.05.010. Epub 2019 May 24.

PMID:
31132589
9.

Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome.

Harrell CR, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V.

Cells. 2019 May 16;8(5). pii: E467. doi: 10.3390/cells8050467. Review.

10.

Deletion of Galectin-3 attenuates acute pancreatitis in mice by affecting activation of innate inflammatory cells.

Stojanovic B, Jovanovic I, Stojanovic BS, Stojanovic MD, Gajovic N, Radosavljevic G, Pantic J, Arsenijevic N, Lukic ML.

Eur J Immunol. 2019 Jun;49(6):940-946. doi: 10.1002/eji.201847890. Epub 2019 Apr 2.

PMID:
30892686
11.

Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity.

Volarevic V, Djokovic B, Jankovic MG, Harrell CR, Fellabaum C, Djonov V, Arsenijevic N.

J Biomed Sci. 2019 Mar 13;26(1):25. doi: 10.1186/s12929-019-0518-9. Review.

12.

Therapeutic Potential of Amniotic Fluid Derived Mesenchymal Stem Cells Based on their Differentiation Capacity and Immunomodulatory Properties.

Harrell CR, Gazdic M, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V.

Curr Stem Cell Res Ther. 2019;14(4):327-336. doi: 10.2174/1574888X14666190222201749. Review.

PMID:
30806325
13.

Galectin-3 Deficiency Facilitates TNF-α-Dependent Hepatocyte Death and Liver Inflammation in MCMV Infection.

Stojanovic B, Milovanovic J, Arsenijevic A, Stojanovic B, Strazic Geljic I, Arsenijevic N, Jonjic S, Lukic ML, Milovanovic M.

Front Microbiol. 2019 Feb 8;10:185. doi: 10.3389/fmicb.2019.00185. eCollection 2019.

14.

The role of galectin-3 in modulation of anxiety state level in mice.

Stajic D, Selakovic D, Jovicic N, Joksimovic J, Arsenijevic N, Lukic ML, Rosic G.

Brain Behav Immun. 2019 May;78:177-187. doi: 10.1016/j.bbi.2019.01.019. Epub 2019 Jan 23.

PMID:
30682502
15.

Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract.

Acovic A, Gazdic M, Jovicic N, Harrell CR, Fellabaum C, Arsenijevic N, Volarevic V.

Therap Adv Gastroenterol. 2018 Dec 6;11:1756284818815334. doi: 10.1177/1756284818815334. eCollection 2018. Review.

16.

IL-33 Prevents MLD-STZ Induction of Diabetes and Attenuate Insulitis in Prediabetic NOD Mice.

Pavlovic S, Petrovic I, Jovicic N, Ljujic B, Miletic Kovacevic M, Arsenijevic N, Lukic ML.

Front Immunol. 2018 Nov 15;9:2646. doi: 10.3389/fimmu.2018.02646. eCollection 2018.

17.

Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric Cancer.

Pavlovic M, Gajovic N, Jurisevic M, Mitrovic S, Radosavljevic G, Pantic J, Arsenijevic N, Jovanovic I.

Gastroenterol Res Pract. 2018 Oct 4;2018:6578273. doi: 10.1155/2018/6578273. eCollection 2018.

18.

Indoleamine 2,3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitis.

Acovic A, Simovic Markovic B, Gazdic M, Arsenijevic A, Jovicic N, Gajovic N, Jovanovic M, Zdravkovic N, Kanjevac T, Harrell CR, Fellabaum C, Dolicanin Z, Djonov V, Arsenijevic N, Lukic ML, Volarevic V.

Therap Adv Gastroenterol. 2018 Aug 24;11:1756284818793558. doi: 10.1177/1756284818793558. eCollection 2018.

19.

Galectin-3 deficiency enhances type 2 immune cell-mediated myocarditis in mice.

Kovacevic MM, Pejnovic N, Mitrovic S, Jovicic N, Petrovic I, Arsenijevic N, Lukic ML, Ljujic B.

Immunol Res. 2018 Aug;66(4):491-502. doi: 10.1007/s12026-018-9013-8.

PMID:
30099675
20.

IL-33 receptor (ST2) deficiency downregulates myeloid precursors, inflammatory NK and dendritic cells in early phase of sepsis.

Babic ZM, Zunic FZ, Pantic JM, Radosavljevic GD, Jovanovic IP, Arsenijevic NN, Lukic ML.

J Biomed Sci. 2018 Jul 12;25(1):56. doi: 10.1186/s12929-018-0455-z.

Supplemental Content

Loading ...
Support Center